MoneyWorks4Me

Kopran - Quaterly Results

08 Aug 2026 Evaluate
The revenue for the June 2026 quarter is pegged at Rs. 627.58 millions, about 22.25% up against Rs. 513.35 millions recorded during the year-ago period.Net profit for the quarter ended June 2026 increased significantly by 91.05% to Rs. 67.21 millions from Rs. 35.18 millions.Operating Profit saw a handsome growth to 113.68 millions from 68.68 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 627.58 513.35 22.25 627.58 513.35 22.25 3056.46 2710.10 12.78
Other Income 29.14 17.98 62.07 29.14 17.98 62.07 19.99 59.04 -66.14
PBIDT 113.68 68.68 65.52 113.68 68.68 65.52 495.75 445.60 11.25
Interest 12.38 10.42 18.81 12.38 10.42 18.81 42.00 37.66 11.52
PBDT 101.30 58.26 73.88 101.30 58.26 73.88 453.75 407.94 11.23
Depreciation 13.48 12.19 10.58 13.48 12.19 10.58 49.81 49.99 -0.36
PBT 87.82 46.07 90.62 87.82 46.07 90.62 403.94 357.95 12.85
TAX 20.61 10.89 89.26 20.61 10.89 89.26 99.94 89.38 11.81
Deferred Tax 1.28 0.09 1322.22 1.28 0.09 1322.22 9.58 3.06 213.07
PAT 67.21 35.18 91.05 67.21 35.18 91.05 304.00 268.57 13.19
Equity 482.86 482.11 0.16 482.86 482.11 0.16 482.86 482.86 0.00
PBIDTM(%) 18.11 13.38 35.39 18.11 13.38 35.39 16.22 16.44 -1.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..